FDA data explorer

Every openFDA database, in one search.

30 datasets, 55,850,846 records: approvals, labels, NDCs, shortages, recalls, adverse event reports, device clearances and UDIs, substances, complete response letters and more. openFDA exported the newest on 2026-10-05.

“testosterone” matches in 21 of 26 searchable datasets. 5 did not answer this time (Drug shortages, Device classification, PMA approvals, COVID-19 serology test evaluations, Food recalls); try again shortly.

Drugs

Orange Book 123

  • TESTOSTERONE

    TESTOSTERONE · 30MG/1.5ML ACTUATION · SOLUTION, METERED · TRANSDERMAL

    ANDA209836DISCONTINUED
    FDA page
  • DELATESTRYL

    TESTOSTERONE ENANTHATE · 200MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION

    NDA009165DISCONTINUED
    FDA page
  • DELATESTRYL

    TESTOSTERONE ENANTHATE · 200MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION

    NDA009165DISCONTINUEDReference listed drug
    FDA page
All 123 in Orange Book →

Drug recalls 25

All 25 in Drug recalls →

Devices

Establishments and listings 97

All 97 in Establishments and listings →

Device recalls 14

All 14 in Device recalls →

Device recall enforcement reports 12

All 12 in Device recall enforcement reports →

Unique device identifiers (GUDID) 140

All 140 in Unique device identifiers (GUDID) →

Device adverse event reports (MAUDE) 118

All 118 in Device adverse event reports (MAUDE) →

Cosmetics

Cosmetic adverse event reports 11

All 11 in Cosmetic adverse event reports →

Food

Food and supplement adverse event reports (CAERS) 147

All 147 in Food and supplement adverse event reports (CAERS) →

Animal & veterinary

Tobacco

Substances & reference

Substances (GSRS) 75

All 75 in Substances (GSRS) →

Historical FDA documents 26

  • For Immediate Release: May 15, 2013

    FDA NEWS RELEASE For Immediate Release: May 15, 2013 En Espafiol FDA approves new drug for advanced prostate cancer Xofigo approved three months ahead of schedule under priority review program The U.S. Food and Drug Admin…

    Press release2 pages
  • For Immediate Release: July 26, 2013

    FDA NEWS RELEASE For Immediate Release: July 26, 2013 En Espafiol FDA warns consumers about health risks with Healthy Life Chemistry dietary supplement Laboratory tests indicate presence of anabolic steroids Today, the U…

    Press release2 pages
  • For Immediate Release: Aug. 31, 2012

    FDA NEWS RELEASE For Immediate Release: Aug. 31, 2012 FDA approves new treatment for a type of late stage prostate cancer The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat men with late…

    Press release2 pages
All 26 in Historical FDA documents →

Transparency

Complete response letters 6

  • Acer Therapeutics Inc. · NDA 214860

    g YN U.S. FOOD & DRUG ADMINISTRATION NDA 214860 COMPLETE RESPONSE Acer Therapeutics Inc. Attention: Renée M. Carroll, MS, RAC Vice President, Head of Regulatory Affairs One Gateway Center, Suite 351…

    COMPLETE RESPONSEApprovedDivision of Rare Diseases and Medical Genetics,Center for Drug Evaluation and Research
  • Marius Pharmaceuticals, LLC · NDA 213953

    g YN U.S. FOOD & DRUG ADMINISTRATION NDA 213953 COMPLETE RESPONSE Marius Pharmaceuticals, LLC Attention: Om Dhingra, CEO 8601 Six Forks Road, Suite 630 Raleigh, NC 27615 Dear Mr. Dhingra: Please refe…

    COMPLETE RESPONSEApprovedCenter for Drug Evaluation and Research
  • Clarus Therapeutics, Inc. · NDA 206089

    suing, ey i St DEPARTMENT OF HEALTH AND HUMAN SERVICES aaa Food and Drug Administration Silver Spring MD 20993 NDA 206089 COMPLETE RESPONSE Clarus Therapeutics, Inc. Attention: Robert E. Dudley, Ph.D…

    COMPLETE RESPONSEApprovedOffice of Drug Evaluation III,Center for Drug Evaluation and Research
All 6 in Complete response letters →
From FDA's records to your order.

Join free with your NPI to buy from vendors whose licenses MedGrid has reviewed, at wholesale pricing.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.